These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
281 related items for PubMed ID: 32040728
1. Value of integrated PET-IVIM MR in assessing metastases in hypermetabolic pelvic lymph nodes in cervical cancer: a multi-parameter study. Xu C, Du S, Zhang S, Wang B, Dong C, Sun H. Eur Radiol; 2020 May; 30(5):2483-2492. PubMed ID: 32040728 [Abstract] [Full Text] [Related]
2. Combinative evaluation of primary tumor and lymph nodes to predict pelvic lymphatic metastasis in cervical cancer: an integrated PET-IVIM MRI study. Xu C, Li X, Shi Y, Wang B, Sun H. Cancer Imaging; 2020 Mar 06; 20(1):21. PubMed ID: 32143736 [Abstract] [Full Text] [Related]
3. Value of integrated PET-IVIM MRI in predicting lymphovascular space invasion in cervical cancer without lymphatic metastasis. Xu C, Yu Y, Li X, Sun H. Eur J Nucl Med Mol Imaging; 2021 Aug 06; 48(9):2990-3000. PubMed ID: 33506309 [Abstract] [Full Text] [Related]
4. Relationship between 18F-FDG PET metabolic parameters and MRI intravoxel incoherent motion (IVIM) histogram parameters and their correlations with clinicopathological features of cervical cancer: evidence from integrated PET/MRI. Du S, Sun H, Gao S, Xin J, Lu Z, Chen Z, Pan S, Guo Q. Clin Radiol; 2019 Mar 06; 74(3):178-186. PubMed ID: 30545566 [Abstract] [Full Text] [Related]
5. Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer. Hong JH, Min KJ, Lee JK, So KA, Jung US, Kim S, Eo JS. Medicine (Baltimore); 2016 Mar 06; 95(9):e2992. PubMed ID: 26945420 [Abstract] [Full Text] [Related]
6. Multiparametric PET/MR (PET and MR-IVIM) for the evaluation of early treatment response and prediction of tumor recurrence in patients with locally advanced cervical cancer. Gao S, Du S, Lu Z, Xin J, Gao S, Sun H. Eur Radiol; 2020 Feb 06; 30(2):1191-1201. PubMed ID: 31493211 [Abstract] [Full Text] [Related]
7. Correlations between intravoxel incoherent motion diffusion-weighted MR imaging parameters and 18F-FDG PET/CT metabolic parameters in patients with vertebral bone metastases: initial experience. Park S, Yoon JK, Chung NS, Kim SH, Hwang J, Lee HY, Kwack KS. Br J Radiol; 2018 Jun 06; 91(1086):20170889. PubMed ID: 29509489 [Abstract] [Full Text] [Related]
8. Application of Simultaneous 18 F-FDG PET With Monoexponential, Biexponential, and Stretched Exponential Model-Based Diffusion-Weighted MR Imaging in Assessing the Proliferation Status of Lung Adenocarcinoma. Huang Z, Li X, Wang Z, Meng N, Fu F, Han H, Li D, Bai Y, Wei W, Fang T, Feng P, Yuan J, Yang Y, Wang M. J Magn Reson Imaging; 2022 Jul 06; 56(1):63-74. PubMed ID: 34888990 [Abstract] [Full Text] [Related]
9. Combinative evaluation of primary tumor and lymph nodes in predicting pelvic lymphatic metastasis in early-stage cervical cancer: A multiparametric PET-CT study. Li K, Sun H, Guo Q. Eur J Radiol; 2019 Apr 06; 113():153-157. PubMed ID: 30927941 [Abstract] [Full Text] [Related]
10. Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer. Fasmer KE, Gulati A, Dybvik JA, Ytre-Hauge S, Salvesen Ø, Trovik J, Krakstad C, Haldorsen IS. Eur Radiol; 2020 May 06; 30(5):2443-2453. PubMed ID: 32034487 [Abstract] [Full Text] [Related]
11. Early treatment response of patients undergoing concurrent chemoradiotherapy for cervical cancer: An evaluation of integrated multi-parameter PET-IVIM MR. Xu C, Sun H, Du S, Xin J. Eur J Radiol; 2019 Aug 06; 117():1-8. PubMed ID: 31307633 [Abstract] [Full Text] [Related]
12. Sensitivity and specificity of amide proton transfer-weighted imaging for assessing programmed death-ligand 1 status in non-small cell lung cancer: a comparative study with intravoxel incoherent motion and 18F-FDG PET. Meng N, Fu F, Sun J, Feng P, Luo Y, Wu Y, Li X, Yuan J, Yang Y, Liu H, Wang Z, Wang M. Quant Imaging Med Surg; 2022 Sep 06; 12(9):4474-4487. PubMed ID: 36060584 [Abstract] [Full Text] [Related]
13. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients. Husby JA, Reitan BC, Biermann M, Trovik J, Bjørge L, Magnussen IJ, Salvesen ØO, Salvesen HB, Haldorsen IS. J Nucl Med; 2015 Aug 06; 56(8):1191-8. PubMed ID: 26045311 [Abstract] [Full Text] [Related]
15. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer. Miccò M, Vargas HA, Burger IA, Kollmeier MA, Goldman DA, Park KJ, Abu-Rustum NR, Hricak H, Sala E. Eur J Radiol; 2014 Jul 06; 83(7):1169-1176. PubMed ID: 24767630 [Abstract] [Full Text] [Related]
16. 18F-FDG PET/CT in immunocompetent patients with primary central nervous system lymphoma: Differentiation from glioblastoma and correlation with DWI. Zhou W, Wen J, Hua F, Xu W, Lu X, Yin B, Geng D, Guan Y. Eur J Radiol; 2018 Jul 06; 104():26-32. PubMed ID: 29857862 [Abstract] [Full Text] [Related]
17. Application of diffusion kurtosis imaging and 18F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer. Feng P, Shao Z, Dong B, Fang T, Huang Z, Li Z, Fu F, Wu Y, Wei W, Yuan J, Yang Y, Wang Z, Wang M. Front Oncol; 2022 Jul 06; 12():989131. PubMed ID: 36248958 [Abstract] [Full Text] [Related]
19. The diagnostic value of metabolic, morphological and heterogeneous parameters of 18F-FDG PET/CT in mediastinal lymph node metastasis of non-small cell lung cancer. Hua J, Li L, Liu L, Liu Q, Liu Y, Chen X. Nucl Med Commun; 2021 Nov 01; 42(11):1247-1253. PubMed ID: 34269750 [Abstract] [Full Text] [Related]